This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1982-1988.
Company Filing History:
Years Active: 1982-1988
Title: The Innovations of Wendell W. Windisch
Introduction
Wendell W. Windisch is a notable inventor based in Groton, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds that enhance antibiotic efficacy. With a total of 2 patents, Windisch's work has had a meaningful impact on medical treatments.
Latest Patents
Among his latest patents is the transformation product of thiosporamicin, which includes sparingly water-soluble salts of penicillanic acid 1,1-dioxide. This invention features the 1:2 N,N'-dibenzylethylenediamine, the N-benzyl-2-phenylethylamine, and the dibenzylamine salts of penicillanic acid 1,1-dioxide. These compounds are recognized as well-known betalactamase inhibitors and are valuable as slow-release forms of penicillanic acid 1,1-dioxide. They are particularly useful in conjunction with slow-release forms of penicillin and cephalosporin antibiotics for the chemotherapy of bacterial infections in mammals.
Career Highlights
Wendell W. Windisch has built a successful career at Pfizer Corporation, where he has been instrumental in advancing pharmaceutical research and development. His innovative approaches have contributed to the creation of effective treatments that address critical health issues.
Collaborations
Throughout his career, Windisch has collaborated with esteemed colleagues, including Charles E. Moppett and William W. Armstrong. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Wendell W. Windisch's contributions to the field of pharmaceuticals exemplify the importance of innovation in medical science. His patents and collaborative efforts continue to influence the development of effective treatments for bacterial infections.